Comments
Loading...

Protalix BioTherapeutics

PLXAMEX
Logo brought to you by Benzinga Data
$1.66
-0.03-1.78%
At close: -
Consensus Rating1
Buy
Highest Price Target1
$10.00
Lowest Price Target1
$10.00
Consensus Price Target1
$10.00

Protalix BioTherapeutics (AMEX:PLX) Stock, Analyst Ratings, Price Targets, Forecasts

Protalix BioTherapeutics Inc has a consensus price target of $10 based on the ratings of 1 analysts. The high is $10 issued by HC Wainwright & Co. on November 14, 2023. The low is $10 issued by HC Wainwright & Co. on November 14, 2023. The 2 most-recent analyst ratings were released by HC Wainwright & Co. on November 14, 2023 and October 31, 2023, respectively. With an average price target of $10 between HC Wainwright & Co., there's an implied 502.41% upside for Protalix BioTherapeutics Inc from these most-recent analyst ratings.

Analyst Rating and Forecast
12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

HC Wainwright & Co.

1calculated from analyst ratings

Analyst Ratings for Protalix BioTherapeutics

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Protalix BioTherapeutics (PLX) stock?

A

The latest price target for Protalix BioTherapeutics (AMEX:PLX) was reported by HC Wainwright & Co. on November 14, 2023. The analyst firm set a price target for $10.00 expecting PLX to rise to within 12 months (a possible 502.41% upside). 0 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Protalix BioTherapeutics (PLX)?

A

The latest analyst rating for Protalix BioTherapeutics (AMEX:PLX) was provided by HC Wainwright & Co., and Protalix BioTherapeutics reiterated their buy rating.

Q

When was the last upgrade for Protalix BioTherapeutics (PLX)?

A

There is no last upgrade for Protalix BioTherapeutics

Q

When was the last downgrade for Protalix BioTherapeutics (PLX)?

A

There is no last downgrade for Protalix BioTherapeutics.

Q

When is the next analyst rating going to be posted or updated for Protalix BioTherapeutics (PLX)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Protalix BioTherapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Protalix BioTherapeutics was filed on November 14, 2023 so you should expect the next rating to be made available sometime around November 14, 2024.

Q

Is the Analyst Rating Protalix BioTherapeutics (PLX) correct?

A

While ratings are subjective and will change, the latest Protalix BioTherapeutics (PLX) rating was a reiterated with a price target of $0.00 to $10.00. The current price Protalix BioTherapeutics (PLX) is trading at is $1.66, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch